Name | 5-chloro-N-(3-chlorophenyl)-2-hydroxybenzamide |
---|---|
Synonyms | 3',5-dichlorosalicylanilide |
Description | SARS-CoV-2-IN-14 (compound 6) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.39 μM. SARS-CoV-2-IN-14 is a niclosamide analogue. SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally[1]. |
---|---|
Related Catalog | |
References |
Density | 1.479g/cm3 |
---|---|
Boiling Point | 361.5ºC at 760 mmHg |
Molecular Formula | C13H9Cl2NO2 |
Molecular Weight | 282.12 |
Flash Point | 172.4ºC |
Exact Mass | 281.00100 |
PSA | 49.33000 |
LogP | 4.02430 |
Vapour Pressure | 9.91E-06mmHg at 25°C |
Index of Refraction | 1.685 |
Storage condition | 2-8°C |
Hazard Codes | Xn |
---|---|
HS Code | 2924299090 |
~87% 22203-98-1 |
Literature: Imramovsky, Ales; Vinsova, Jarmila; Ferriz, Juana Monreal; Kunes, Jiri; Pour, Milan; Dolezal, Martin Tetrahedron Letters, 2006 , vol. 47, # 29 p. 5007 - 5011 |
HS Code | 2924299090 |
---|---|
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |